Security key
10806X102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 144,623,389
- Total 13F value
- $1,101,997,850
- Share change
- -793,190
- Put/Call ratio
- 41%
- SEC-reported price per share
- $7.62
- Number of holders
- 175
- Value change
- -$14,634,842
- Number of buys
- 76
- Number of sells
- 87
- Shares outstanding
- 193,965,216
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
175
Top holders
10
BBIO full security history
Ownership snapshot
Full 13F holder table
BridgeBio Pharma, Inc. SEC filings
BridgeBio Pharma, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of BBIO - BridgeBio Pharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kohlberg Kravis Roberts &...
Disclosed value leader
Kohlberg Kravis Roberts &...
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F
Highest disclosed value: $308,746,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Kohlberg Kravis Roberts & Co. L.P. has the largest disclosed position value at $308.75M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kohlberg Kravis Roberts & Co. L.P.'s linked filing trail.
Disclosed position value
Top 5
Kohlberg Kravis Roberts & Co. L.P.
$308.75M
VIKING GLOBAL INVESTORS LP
$264.61M
VANGUARD GROUP INC
$99.44M
BlackRock Finance, Inc.
$92.1M
STATE STREET CORP
$78.95M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. |
13F
Company
|
—
denominator unverified
|
$308,746,000
31,060,971 shares
|
— | 30 Sep 2022 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
—
denominator unverified
|
$264,613,000
26,620,991 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$99,442,000
10,004,271 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$92,103,000
9,265,868 shares
|
— | 30 Sep 2022 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$78,952,000
7,942,811 shares
|
— | 30 Sep 2022 |
| Aisling Capital Management LP |
13F
Company
|
—
denominator unverified
|
$60,317,000
6,068,125 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
175
Shares
144,623,389
Rows available
175
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
170
Q4 2022 holders
175
Holder diff
5
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|